Market Overview

UPDATE: Eli Lilly Posts Downbeat Q3 Profit

Related LLY
AC Immune Is An Alzheimer's Pure Play With A Lot On The Line
Anavex Life Sciences Joins The Club Of Stocks Moving Higher On News Of Alzheimer's Research
Here's How Lilly And Merck Are Faring In The Cancer Drug Wars: Earnings Out Next Week (Seeking Alpha)

Eli Lilly & Co (NYSE: LLY) reported a 7.3% rise in its third-quarter net income.

Eli Lilly's quarterly earnings surged to $1.33 billion, or $1.18 per share, versus $1.24 billion, or $1.11 per share, in the year-ago quarter. Its adjusted earnings came in at $0.79 per share.

Its revenue dropped to $5.44 billion from $6.15 billion. However, analysts were expecting a profit of $0.84 per share on revenue of $5.63 billion.

For full-year 2012, Eli Lilly now projects earnings of $3.68 to $3.78 per share, versus $3.90 per share in 2011. On an adjusted basis, Eli Lilly expects earnings of $3.30 to $3.40 per share.

Eli Lilly shares closed at $51.91 yesterday.

Posted-In: profitEarnings News Guidance


Related Articles (LLY)

View Comments and Join the Discussion!